Updated final guidance on addressing cybersecurity in medical device quality systems and premarket submissions and an enforcement discretion policy for special controls imposed on laboratory developed tests (LDTs) are among the FDA’s top priorities for device guidance document development over the next 12 months. On Oct. 10, the agency’s Center for Devices and Radiological He... Read More